SOX9 anticorps (AA 400-509)
-
- Antigène Voir toutes SOX9 Anticorps
- SOX9 (SRY (Sex Determining Region Y)-Box 9 (SOX9))
-
Épitope
- AA 400-509
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp SOX9 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP)
- Fonction
- Mouse monoclonal antibody raised against a partial recombinant SOX9.
- Séquence
- EQLSPSHYSE QQQHSPQQIA YSPFNLPHYS PSYPPITRSQ YDYTDHQNSS SYYSHAAGQG TGLYSTFTYM NPAQRPMYTP IADTSGVPSI PQTHSPQHWE QPVYTQLTRP
- Réactivité croisée
- Humain
- Attributs du produit
- Antibody Reactive Against Recombinant Protein.
- Immunogène
- SOX9 (NP_000337, 400 a.a. ~ 509 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
- Clone
- 3C10
- Isotype
- IgG2a
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Buffer
- In 1x PBS, pH 7.4
- Conseil sur la manipulation
- Aliquot to avoid repeated freezing and thawing.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
In vitro osteogenic potential of human mesenchymal stem cells is predicted by Runx2/Sox9 ratio." dans: Tissue engineering. Part A, Vol. 21, Issue 1-2, pp. 115-23, (2015) (PubMed).
: "Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome." dans: Journal of clinical pathology, Vol. 67, Issue 2, pp. 125-33, (2014) (PubMed).
: "Supra- and infratentorial pediatric ependymomas differ significantly in NeuN, p75 and GFAP expression." dans: Journal of neuro-oncology, Vol. 112, Issue 2, pp. 191-7, (2013) (PubMed).
: "A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue." dans: The American journal of pathology, Vol. 177, Issue 4, pp. 1674-86, (2010) (PubMed).
: "
-
In vitro osteogenic potential of human mesenchymal stem cells is predicted by Runx2/Sox9 ratio." dans: Tissue engineering. Part A, Vol. 21, Issue 1-2, pp. 115-23, (2015) (PubMed).
-
- Antigène
- SOX9 (SRY (Sex Determining Region Y)-Box 9 (SOX9))
- Autre désignation
- SOX9 (SOX9 Produits)
- Synonymes
- anticorps CMD1, anticorps CMPD1, anticorps SRA1, anticorps LOC100227849, anticorps 2010306G03Rik, anticorps AV220920, anticorps mKIAA4243, anticorps SOX-9, anticorps cmd1, anticorps cmpd1, anticorps sox-9, anticorps sox9, anticorps sox9-a, anticorps sox9-b, anticorps sox9b, anticorps sra1, anticorps SRY-box 9, anticorps transcription factor SOX-9, anticorps SRY (sex determining region Y)-box 9, anticorps SRY box 9, anticorps SRY-box 9 L homeolog, anticorps SOX9, anticorps LOC100227849, anticorps Sox9, anticorps sox9.L
- Sujet
-
Full Gene Name: SRY (sex determining region Y)-box 9
Synonyms: CMD1,CMPD1,SRA1 - ID gène
- 6662
- NCBI Accession
- NM_000346
- Pathways
- EGFR Signaling Pathway, Stem Cell Maintenance, Regulation of Muscle Cell Differentiation, Tube Formation, Skeletal Muscle Fiber Development
-